Isnain, Merlyn S.

HRN: 16-99-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2022
CEFUROXIME 1.5GM (VIAL)
11/16/2022
11/16/2022
IV
1.5g
Now
Prim LTCS
Waiting Final Action 
11/16/2022
CEFUROXIME 1.5GM (VIAL)
11/16/2022
11/17/2022
IVTT
1.5gram
Q8hrs
For Prophylaxis For Surgical Infection
Waiting Final Action 
11/16/2022
CEFUROXIME 500MG (TAB)
11/16/2022
11/22/2022
ORAL
500mg
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: